AVATANEO, VALERIA
 Distribuzione geografica
Continente #
NA - Nord America 1.429
EU - Europa 611
AS - Asia 281
AF - Africa 21
SA - Sud America 7
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.353
Nazione #
US - Stati Uniti d'America 1.422
IT - Italia 205
CN - Cina 158
IE - Irlanda 112
SE - Svezia 78
AT - Austria 61
DE - Germania 36
FR - Francia 30
VN - Vietnam 24
HK - Hong Kong 19
IN - India 19
SG - Singapore 17
UA - Ucraina 16
ZA - Sudafrica 13
GB - Regno Unito 11
BE - Belgio 10
FI - Finlandia 10
TH - Thailandia 10
KR - Corea 7
NG - Nigeria 6
NL - Olanda 6
CA - Canada 5
CH - Svizzera 5
DK - Danimarca 5
JP - Giappone 5
PL - Polonia 5
CL - Cile 4
GR - Grecia 4
RO - Romania 4
TW - Taiwan 4
AU - Australia 3
ID - Indonesia 3
TR - Turchia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
CO - Colombia 2
CZ - Repubblica Ceca 2
ES - Italia 2
HU - Ungheria 2
IR - Iran 2
PT - Portogallo 2
SA - Arabia Saudita 2
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CR - Costa Rica 1
DZ - Algeria 1
EU - Europa 1
IQ - Iraq 1
JO - Giordania 1
LI - Liechtenstein 1
LV - Lettonia 1
MK - Macedonia 1
MX - Messico 1
PK - Pakistan 1
SN - Senegal 1
Totale 2.353
Città #
Chandler 304
Dublin 112
Torino 87
Fairfield 80
Houston 77
Beijing 69
Ashburn 65
Ann Arbor 61
Vienna 59
Dearborn 54
Nyköping 53
Woodbridge 52
Princeton 34
Medford 33
Turin 29
Cambridge 28
Wilmington 22
Fremont 21
Jacksonville 19
Villeurbanne 19
Washington 15
New York 14
Hangzhou 13
Redwood City 13
Seattle 12
Singapore 12
Dong Ket 11
Central 10
Brussels 9
Norwalk 9
Boardman 8
Hebei 8
Rome 8
Abuja 6
Boston 6
Nanjing 6
Seoul 6
Alberton 5
Chengdu 5
Esslingen am Neckar 5
Guangzhou 5
Pisa 5
Pune 5
Buffalo 4
Guiyang 4
Nanchang 4
San Diego 4
Taipei 4
Toronto 4
Warsaw 4
Bolano 3
Brooklyn 3
Chongqing 3
Columbus 3
Durban 3
Frankfurt am Main 3
Grapevine 3
Hong Kong 3
Lappeenranta 3
Los Angeles 3
Shanghai 3
Shenzhen 3
Varde 3
Aachen 2
Bangkok 2
Bassano del Grappa 2
Berlin 2
Bossonnens 2
Budapest 2
Central District 2
Chatsworth 2
Chiang Mai 2
Chicago 2
Dallas 2
Delhi 2
Dubai 2
Genoa 2
Hefei 2
Helsinki 2
Hyderabad 2
Jinan 2
Kosekoy 2
Kunming 2
London 2
Medellín 2
Melbourne 2
Mele 2
Milan 2
Nagold 2
Neubiberg 2
New Delhi 2
Novy Jicin 2
Parma 2
Peristeri 2
Piemonte 2
Pyhra 2
Ridgeland 2
Riverside 2
Saluzzo 2
Santiago 2
Totale 1.615
Nome #
Pharmacogenetic determinants of kidney-associated urinary and serum abnormalities in antiretroviral-treated HIV-positive patients 176
A simple high performance liquid chromatography-mass spectrometry method for Therapeutic Drug Monitoring of isavuconazole and four other antifungal drugs in human plasma samples 136
Striatal astrocytes produce neuroblasts in an exicitotoxic model of Huntington's disease. 135
Vitamin D pathway genetic variants are able to influence sofosbuvir and its main metabolite pharmacokinetics in HCV mono-infected patients 124
25-hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2 122
Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients with Primary Aldosteronism 107
Cannabinoids concentration variability in cannabis olive oil galenic preparations 104
Vitamin D pathway gene polymorphisms and hepatocellular carcinoma in chronic hepatitis C-affected patients treated with new drugs 87
A simple UHPLC-PDA method with a fast dilute-and-shot sample preparation for the quantification of canrenone and its prodrug spironolactone in human urine samples 84
Validation of a UHPLC-MS/MS Method to Quantify Twelve Antiretroviral Drugs within Peripheral Blood Mononuclear Cells from People Living with HIV 82
Real life Study on the Pharmacokinetic of Remdesivir in ICU patients admitted for Severe COVID-19 Pneumonia 74
Effect of ABCC2 and ABCG2 Gene Polymorphisms and CSF-to-Serum Albumin Ratio on Ceftriaxone Plasma and Cerebrospinal Fluid Concentrations 72
Role of CYP1A1, ABCG2, CYP24A1 and VDR gene polymorphisms on the evaluation of cardiac iron overload in thalassaemia patients 71
Influence of ABCB11 and HNF4α genes on daclatasvir plasma concentration: preliminary pharmacogenetic data from the Kineti-C study 66
The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients 62
UHPLC-MS/MS method with sample dilution to test therapeutic adherence through quantification of ten antihypertensive drugs in urine samples 62
Assessment of Anti-Hypertensive Drug Adherence by Serial Aldosterone-To-Renin Ratio Measurement 62
Pharmacogenetic of voriconazole antifungal agent in pediatric patients 60
Analytical validation and clinical application of rapid serological tests for sars-cov-2 suitable for large-scale screening 60
Therapeutic drug monitoring guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence 57
Pharmacogenetics of the anti-HCV drug sofosbuvir: a preliminary study 56
Development and Validation of an Up-to-Date Highly Sensitive UHPLC-MS/MS Method for the Simultaneous Quantification of Current Anti-HIV Nucleoside Analogues in Human Plasma 55
Older Age is Associated with Higher Dolutegravir Exposure in Plasma and Cerebrospinal Fluid of People Living with HIV 51
A Non-Invasive Method for Detection of Antihypertensive Drugs in Biological Fluids: The Salivary Therapeutic Drug Monitoring 50
Effect of Gender and Age on Voriconazole Trough Concentrations in Italian Adult Patients 46
Factors Influencing the Intracellular Concentrations of the Sofosbuvir Metabolite GS-331007 (in PBMCs) at 30 Days of Therapy 46
LC-MS application for therapeutic drug monitoring in alternative matrices 45
Vitamin D as Modulator of Drug Concentrations: A Study on Two Italian Cohorts of People Living with HIV Administered with Efavirenz 45
Validation and Clinical Application of a New Liquid Chromatography Coupled to Mass Spectrometry (HPLC-MS) Method for Dalbavancin Quantification in Human Plasma 44
UHPLC-MS/MS method with protein precipitation extraction for the simultaneous quantification of ten antihypertensive drugs in human plasma from resistant hypertensive patients 43
Seasonal variation of antiretroviral drug exposure during the year: The experience of 10 years of therapeutic drug monitoring 43
Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19 39
Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola virus disease 37
Monthly Increase in Vitamin D Levels upon Supplementation with 2000 IU/Day in Healthy Volunteers: Result from “Integriamoci”, a Pilot Pharmacokinetic Study 32
Antiretroviral Levels in the Cerebrospinal Fluid: The Effect of Inflammation and Genetic Variants 15
A pharmacogenetic study in HIV-infected patients treated with ritonavir: hematological and cardiovascular disease risk analysis 13
Totale 2.463
Categoria #
all - tutte 8.723
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.723


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201923 0 0 0 0 0 0 0 0 0 0 9 14
2019/2020278 3 7 1 17 5 55 25 16 46 74 19 10
2020/2021316 14 18 9 17 22 25 24 18 49 26 39 55
2021/2022424 20 20 22 19 29 50 19 19 5 18 118 85
2022/2023814 68 88 29 76 66 171 44 79 87 24 45 37
2023/2024300 49 51 40 20 21 50 6 8 17 21 17 0
Totale 2.463